Takeru Furuya

Takeru Furuya

Principal atXontogenyMassachusetts

Takeru Furuya is a Principal at Xontogeny, bringing over 10 years of drug discovery experience. He previously held roles at Astellas Pharma, Entasis Therapeutics, and co-founded SciFluor Life Sciences.

What Takeru can write

Writes checks ofNot reported
Comes in atSeedMostly follows a lead
Email the firm[email protected]The firm's own inbox for founders.

Career

  1. SciFluor Life Sciences · Co-founder and Director of Chemistry
  2. Astellas Pharma · Associate Director of Medicinal Chemistry
  3. Entasis Therapeutics · Associate Director of Medicinal Chemistry
  4. Xontogeny · Principal
    Now
  5. Xontogeny · Senior Associate
    Now

Companies founded

SciFluor Life Sciences

Focus

cns/pnsophthalmicinfectiouscardiovascularmetabolic diseasesdrug discovery

Education

Harvard University, PhD in Chemistry and Chemical BiologyUniversity of Tokyo, BS in Pharmaceutical Science

Also at Xontogeny

Partners like Takeru

At firms with a similar stage, sector and check size.

Alert me when Xontogeny is active

One email when Takeru's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Takeru Furuya?

Takeru Furuya is a Principal at Xontogeny, bringing over 10 years of drug discovery experience. He previously held roles at Astellas Pharma, Entasis Therapeutics, and co-founded SciFluor Life Sciences.

How much does Takeru Furuya invest?

Xontogeny has not reported a check size. It invests at seed.

How do I pitch Takeru Furuya?

Email [email protected], the firm's inbox for founders, and name Takeru in the subject. A warm intro from a founder Xontogeny backed works better.

What did Takeru Furuya do before Xontogeny?

Co-founder and Director of Chemistry at SciFluor Life Sciences; Associate Director of Medicinal Chemistry at Astellas Pharma; Associate Director of Medicinal Chemistry at Entasis Therapeutics.

Last updated 2026-10-15. Is this you? Ask for a correction.